Embark Delta Inc. Unveils Next Generation of 2.0 Brands and Products Leveraging Proprietary Embark Nano Technology

0
25

Toronto, Ontario–(Newsfile Corp. – April 21, 2021) – Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. (“Embark” or the “Company”) is pleased to announce the exciting launch of its suite of products from Embark Nano’s groundbreaking technology. New offerings launched in the coming weeks include a dynamic variety of infused adult-use topicals and liquid beverage-shots. Additional products launching throughout 2021 will include the water-soluble powdered beverage mix, formulated with the modern cannabis consumer in mind.

“We are excited to announce the launch of these innovative and industry-leading products as part of Embark’s brand portfolio and product line expansion,” said Dr. Luc C. Duchesne, Embark’s CEO. “These robust offerings will soon be made available to consumers in Alberta, B.C., Saskatchewan and Manitoba in the very near future, and we look forward to continuing to expand our product portfolio for them to enjoy.”

Embark’s Chief Commercial Officer, Stephanie Fry added, “We are proud to introduce the Distilled + Infused and Meridian brands which offer new options for cannabis consumption outside of existing choices in market. Furthermore, the beverage and topical categories provide consumers alternatives when seeking the next generation of cannabis products that are best in class, discreet, packaged in convenient sizes and easy to use.”

Cannot view this image? Visit: https://i1.wp.com/grassnews.net/wp-content/uploads/2021/04/embark-delta-inc-unveils-next-generation-of-2-0-brands-and-products-leveraging-proprietary-embark-nano-technology.jpg?w=696&ssl=1

Distilled and Infused

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7351/81146_2d906457541d8912_001full.jpg

Distilled + Infused is Embark’s first product offering in the beverage category and comes in two different SKUs. The initial launch includes the THC-infused Liquid Shot and the CBD-Infused Liquid Shot. Both options are unflavoured and can be mixed with the consumers beverage of choice. Embark will be launching flavoured shots later in 2021 starting with the strawberry lemonade and raspberry flavours; all of which are naturally-flavoured, gluten-free, and plant-based.

Packaged in a convenient “grab and go” option, all varieties contain Embark Nano’s proprietary bitter blocking formula, which eliminates any bitter taste typically found in current market offerings. When combined with your preferred drink, the Liquid Shot results in a clear, translucent blend that does not compromise taste or flavour and requires no stirring. The Distilled + Infused Liquid Shot is ideal for those who desire an alternative to traditional cannabis consumption or beverage alternative to alcoholic beverages.

As with all cannabis, do not mix with alcohol. Sip responsibly. Must be legal age.

Embark will be launching the Distilled + Infused Powdered Beverage Mix later in the year. The Powdered Beverage Mix will be available in unflavoured, lemon, lime, and orange flavours.

Cannot view this image? Visit: https://i2.wp.com/grassnews.net/wp-content/uploads/2021/04/embark-delta-inc-unveils-next-generation-of-2-0-brands-and-products-leveraging-proprietary-embark-nano-technology-1.jpg?w=696&ssl=1

Meridian

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7351/81146_2d906457541d8912_002full.jpg

Embark is also pleased to bring the Meridian brand to market in Canada. The first product to launch under this brand is the luxurious, all-in-one topical cream. The Meridian cream is available in THC and CBD, 1 and 2oz jars with the argan-vanilla scent; additional scents will follow. The Meridian products are suitable for daily use, paraben-free, scented with organic natural extracts, contain no synthetic perfumes or scents or volatile compounds, and no formaldehyde-releasing preservatives.

Meridian is the first of its kind in the Canadian market. It utilizes the Embark Nano delivery technology, which shortens the initial onset time of THC effects and allows for transdermal and rapid systemic absorption. The Meridian cream is ideal for those looking for skin care attributes of nourishing hydration in conjunction with wellness properties.

Embark Nano’s state-of-the-art delivery technologies have been observed to increase the efficiency and speed at which the body absorbs vitamins, nutraceuticals, and oil extracts, all while providing a best-in-class experience. We are proud to be launching this incredible brand portfolio and look forward to becoming an industry leader for beauty, health and wellness focused consumers. We are continuing our journey to become a national leader in the end-to-end development and manufacture of innovative, natural, cannabinoid-based concentrates and related products.

In parallel with the release of these new offerings, Embark is thrilled to be engaging with consumers through a roster of social media channels to showcase new products. You can find EmbarkNano online on LinkedIn. Make sure you follow Distilled + Infused on Instagram and Facebook and follow Meridian on Instagram and Facebook.

About Embark Health Inc.

Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical, and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. Building on Embark’s strength in innovation and creating industry-leading Cannabis 2.0 products, it recently announced new product offerings through its proprietary ground-breaking Embark Nano technology. The new suite of products coming to market include cannabis-infused beverages, topicals, edibles and water-soluble powders.

Embark-managed brands of next generation 2.0 products include The Hank Co. and The Hazel Co. under its line of solventless products, and, Distilled + Infused and Meridian under its line of beverage and topical products that utilizes the Embark Nano Technology.

It is Embark’s mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.

Investor Relations Contact:
IR@embarkhealthinc.com

FORWARD LOOKING STATEMENTS

This news release contains “forward-looking information” within the meaning of applicable securities laws including statements regarding the ability to leverage its existing Cannabis 2.0 products for the Canadian market, access to future markets, Embark’s ability to increase production and offer new products and services following receipt of applicable licences, the continued business-to-business activities of Embark, and the effects of the aforementioned activities on the operational and financial condition of Embark. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.

NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81146

LEAVE A REPLY

Please enter your comment!
Please enter your name here